Companies: 10,795·Total market cap: $144.5T
Cingulate Inc.

Cingulate Inc.

CINGNASDAQHealthcare● Active
$4.53
+$0.04(+0.78%)
Market Cap$25395352
P/E Ratio—
52W High$11.89
52W Low$3.16
SEC Filings

Cingulate Inc. (CING) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001862150 · CING · NASDAQ · as of Jun 8, 2026

Filing snapshot

473
Total Filings
8-K
Latest Form
2026-06-02
Most Recent
2021
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001862150 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-18
Fiscal Year End
Mar 18, 2026
Accession No.
0001493152-26-010882
Primary Document
form10-k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001862150 · Accession 0001493152-26-010882

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-14
View 10-Q on SEC
8-KCurrent Report
8-K
2026-06-02Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
8-K
2026-06-02
View
DEF 14AProxy Statement
DEF 14A
2026-05-29
View
ARSARS
ARS
2026-05-29
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-05-29
View
8-KCurrent Report
8-K
2026-05-19
View
PRE 14APRE 14A
PRE 14A
2026-05-18
View
10-QQuarterly Report
10-Q
2026-05-14
View
8-KCurrent Report
8-K
2026-05-14
View
424B3424B3
424B3
2026-04-28
View
EFFECTEFFECT
EFFECT
2026-04-24
View
CORRESPCORRESP
CORRESP
2026-04-22
View
UPLOADUPLOAD
UPLOAD
2026-04-17
View
S-3Shelf Registration
S-3
2026-04-14
View
8-KCurrent Report
8-K
2026-04-02
View
424B3424B3
424B3
2026-03-27
View
Showing 1–15 of 332 filingsForm 4 / 144 hidden· 473 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001862150  |  Exchange: NASDAQ · Healthcare

Cingulate Inc. (NASDAQ: CING) has submitted 473 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2021. As a Healthcare sector company with CIK 0001862150, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Cingulate Inc.'s most comprehensive regulatory disclosure. The most recent Cingulate Inc. 10-K was filed on 2026-03-18 for fiscal year ending 2026. Historical CING 10-K annual reports are available from 2021 through 2026.

Investors researching Cingulate Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
LIXT SEC Filings →ALLR SEC Filings →ENTO SEC Filings →LEXX SEC Filings →NCNA SEC Filings →KAPA SEC Filings →SYBX SEC Filings →BCTX SEC Filings →
→ CING Financials→ CING Earnings→ CING Insider Trades

Frequently Asked Questions

CING SEC Filings · 8 questions

Cingulate Inc. (CING) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 473 filings and access original documents at no cost. Cingulate Inc.'s CIK is 0001862150.

CING SEC filingsCingulate Inc. SEC documentsfind CING 10-K